These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17556664)

  • 1. LOX-1 and atherosclerosis: proof of concept in LOX-1-knockout mice.
    Morawietz H
    Circ Res; 2007 Jun; 100(11):1534-6. PubMed ID: 17556664
    [No Abstract]   [Full Text] [Related]  

  • 2. Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet.
    Mehta JL; Sanada N; Hu CP; Chen J; Dandapat A; Sugawara F; Satoh H; Inoue K; Kawase Y; Jishage K; Suzuki H; Takeya M; Schnackenberg L; Beger R; Hermonat PL; Thomas M; Sawamura T
    Circ Res; 2007 Jun; 100(11):1634-42. PubMed ID: 17478727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis.
    Ishigaki Y; Katagiri H; Gao J; Yamada T; Imai J; Uno K; Hasegawa Y; Kaneko K; Ogihara T; Ishihara H; Sato Y; Takikawa K; Nishimichi N; Matsuda H; Sawamura T; Oka Y
    Circulation; 2008 Jul; 118(1):75-83. PubMed ID: 18559699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LOX-1 deletion decreases collagen accumulation in atherosclerotic plaque in low-density lipoprotein receptor knockout mice fed a high-cholesterol diet.
    Hu C; Dandapat A; Sun L; Chen J; Marwali MR; Romeo F; Sawamura T; Mehta JL
    Cardiovasc Res; 2008 Jul; 79(2):287-93. PubMed ID: 18453637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidized LDL, LOX-1 and atherosclerosis.
    Mitra S; Goyal T; Mehta JL
    Cardiovasc Drugs Ther; 2011 Oct; 25(5):419-29. PubMed ID: 21947818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lectin-like oxidized low-density lipoprotein receptor-1 promotes endothelial dysfunction in LDL receptor knockout background.
    Hofmann A; Brunssen C; Poitz DM; Langbein H; Strasser RH; Henle T; Ravens U; Morawietz H
    Atheroscler Suppl; 2017 Nov; 30():294-302. PubMed ID: 29096854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular signaling of LOX-1 in endothelial cell apoptosis.
    Li D; Mehta JL
    Circ Res; 2009 Mar; 104(5):566-8. PubMed ID: 19286611
    [No Abstract]   [Full Text] [Related]  

  • 8. Restraint stress up-regulates lectin-like oxidized low-density lipoprotein receptor-1 in aorta of apolipoprotein E-deficient mice.
    Andersson IJ; Sankaralingam S; Davidge ST
    Stress; 2010 Sep; 13(5):454-60. PubMed ID: 20666645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders.
    Mehta JL; Chen J; Hermonat PL; Romeo F; Novelli G
    Cardiovasc Res; 2006 Jan; 69(1):36-45. PubMed ID: 16324688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice.
    Sun L; Ishida T; Yasuda T; Kojima Y; Honjo T; Yamamoto Y; Yamamoto H; Ishibashi S; Hirata K; Hayashi Y
    Cardiovasc Res; 2009 May; 82(2):371-81. PubMed ID: 19176597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LOX-1: a multiligand receptor at the crossroads of response to danger signals.
    Sawamura T; Kakino A; Fujita Y
    Curr Opin Lipidol; 2012 Oct; 23(5):439-45. PubMed ID: 22777292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No effect of C-reactive protein on early atherosclerosis in LDLR-/- / human C-reactive protein transgenic mice.
    Torzewski M; Reifenberg K; Cheng F; Wiese E; Küpper I; Crain J; Lackner KJ; Bhakdi S
    Thromb Haemost; 2008 Jan; 99(1):196-201. PubMed ID: 18217154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atherosclerosis and the Lectin-like OXidized low-density lipoprotein scavenger receptor.
    Vohra RS; Murphy JE; Walker JH; Ponnambalam S; Homer-Vanniasinkam S
    Trends Cardiovasc Med; 2006 Feb; 16(2):60-4. PubMed ID: 16473764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oxidized low-density lipoprotein receptor mediates vascular effects of inhaled vehicle emissions.
    Lund AK; Lucero J; Harman M; Madden MC; McDonald JD; Seagrave JC; Campen MJ
    Am J Respir Crit Care Med; 2011 Jul; 184(1):82-91. PubMed ID: 21493736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice.
    Shiraishi Y; Watanabe T; Suguro T; Nagashima M; Kato R; Hongo S; Itabe H; Miyazaki A; Hirano T; Adachi M
    J Hypertens; 2008 Oct; 26(10):1955-65. PubMed ID: 18806619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherosclerosis: cell biology and lipoproteins.
    Lu H; Daugherty A
    Curr Opin Lipidol; 2009 Dec; 20(6):528-9. PubMed ID: 19935204
    [No Abstract]   [Full Text] [Related]  

  • 17. Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) in atherogenesis: a brief review.
    Reiss AB; Anwar K; Wirkowski P
    Curr Med Chem; 2009; 16(21):2641-52. PubMed ID: 19601801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LOX-1, a bridge between GLP-1R and mitochondrial ROS generation in human vascular smooth muscle cells.
    Dai Y; Mercanti F; Dai D; Wang X; Ding Z; Pothineni NV; Mehta JL
    Biochem Biophys Res Commun; 2013 Jul; 437(1):62-6. PubMed ID: 23806684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LOX-1 and obesity.
    Yan M; Mehta JL; Hu C
    Cardiovasc Drugs Ther; 2011 Oct; 25(5):469-76. PubMed ID: 21881850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute elevation of plasma PLTP activity strongly increases pre-existing atherosclerosis.
    Moerland M; Samyn H; van Gent T; van Haperen R; Dallinga-Thie G; Grosveld F; van Tol A; de Crom R
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1277-82. PubMed ID: 18421000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.